About Us
Corporate Overview
Konectix Pte Ltd is a Singapore-registered private limited company engaged in the global wholesale trade of pharmaceutical products and consumer goods. Established in 2012, the company serves as a strategic link between high-quality manufacturers in Asia and a diverse customer base across West Africa, Sri Lanka, Jamaica, and other emerging markets.
Singapore’s reputation as a global trade and logistics hub provides Konectix with an ideal platform for managing procurement, documentation, and exports efficiently. The company’s supply partnerships are primarily concentrated in Asian countries and More Latin American markets with products tailored to the needs of developing markets through competitive pricing and regulatory compliance.
Company Profile
Company Name: Konectix Pte Ltd
UEN: 201210280Z
Registered Address: 2 Joo Chiat Road, #03-1121, Joo Chiat Complex, Singapore 420002
Principal Activity: Wholesale Trade of a Variety of Goods Without a Dominant Product (SSIC Code: 46900)
Nature of Business
Pharmaceutical & Healthcare Division
Consumer Products Division
Supply Chain & Market Operations
Konectix Pte Ltd operates through an optimized sourcing and logistics framework that supports timely shipments, reliable documentation, and end-to-end coordination. With suppliers concentrated in India, Myanmar and other international marketers with a growing network of buyers across Africa, the Caribbean, and Southeast Asia, the company ensures consistent flow of goods with minimal lead times.
The company’s operations are supported by a lean structure, minimizing overhead while maintaining high responsiveness to client requirements. Strong relationships with regional freight forwarders and agents allow Konectix to adapt quickly to market conditions and manage shipments in bulk or by demand.
Global Reach and Future outlook
With over a decade of trading experience and long-standing relationships in West Africa, Sri Lanka, Jamaica, and Latin America, Konectix has steadily expanded its footprint. It is now actively developing its presence in new markets to reach broader Middle East and Latin American Markets and North Asian countries.
The company is also investing in enhanced supply chain systems, including AI-driven inventory and logistics monitoring, aimed at improving delivery timelines, inventory control, and operational transparency.
Financial Strength and Outlook
Konectix has demonstrated healthy revenue growth over recent years, with estimated annual turnover in the range of SGD 4–5 million, and a consistent year-on-year growth rate of 18–22%. The business operates without external debt, reinvesting earnings into working capital, product expansion, and market development.
The strategic investments are targeted at expanding the company’s consumer wellness product line and improving its procurement capabilities across Asia. A portion of reinvestment—approximately 15% of annual earnings—is directed toward technology upgrades, compliance systems, and trade financing readiness.
The company’s forward-looking strategy includes further diversification into Latin American markets, especially Costa Rica, Panama, and Colombia, where demand for affordable pharmaceuticals and consumer goods is rapidly rising.
In essence, exports is global village and we, Konectix acts as a bridge between the manufacturers/suppliers and who look for export turnover, with that of the clients spread across the globe. Thus, facilitating both ends as exports and imports.
We earn sizeable contribution and also contributes towards Tax for the overall economy of the Singapore as a nation.
